In this issue:
Ceritinib active in ROS1-rearranged NSCLC
Alectinib vs crizotinib in untreated ALK + NSCLC
The Bim deletion polymorphism affects response to crizotinib
Atezolizumab promising in metastatic NSCLC
SABR in stage I NSCLC: long-term follow-up data
Comparing post-CRT surgical approaches in rectal carcinoma
The role of checkpoint inhibitors in dMMR mCRC
Management of stage III CRC in the elderly
Peri- vs postoperative CRT in resectable gastric/GOJ AC
Adjuvant radiotherapy improves overall survival in patients with resected gastric adenocarcinoma
Please login below to download this issue (PDF)